The increase suggests that disruptions in important healthcare screenings due to the pandemic are tapering off, according to Bloomberg.
As procedures like early-detection cancer screenings declined in 2020, Mr. Cordani said the payer focused on getting patients back to their providers.
“It’s a very good thing and something that our team has worked tirelessly to try to effectuate, elevating those levels,” Mr. Cordani said in a call with analysts May 7.